Helmerich & Payne: UBS raises target price to $50 from $49
HP•UBS raised its target price for Helmerich & Payne to $50 from $49.
Related News
Tectonic Therapeutic initiates coverage with neutral rating and $26 target price
TECX•
Applied Materials reportedly unveils $5 billion research facility in Silicon Valley to streamline AI chipmaking
AMAT•
Steris doubles down on healthcare consumables with $2.1 billion Xodus buy
STE•
Consolidated Water unit wins $39.8 million Pismo Beach water-treatment design-build contract
CWCO•
Nasdaq trade halt continues; reason not available at 9:35 a.m.
UCFI•